News >

Evidence-Based Strategies Help Guide Need for ALND in Breast Cancer

Jessica Hergert
Published: Sunday, Apr 05, 2020

Anees B. Chagpar, MD, MSc, MPH, MA, MBA

Anees B. Chagpar, MD, MSc, MPH, MA, MBA

Axillary lymph node dissection (ALND) is the standard of care for patients with breast cancer who have positive sentinel lymph nodes after neoadjuvant chemotherapy, said Anees B. Chagpar, MD, MBA, MPH, FACS, FRCS(C). However, several evidence-based strategies may inform which patients can be spared the invasive procedure and of the toxicities associated with the approach. 
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication